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Abstract The expression of interphotoreceptor retinoid binding
protein (IRBP) is limited to photoreceptor cells of the retina and
pinealocytes of the pineal gland. We sought to define cis-elements
of the mouse IRBP 5P flanking region that are required for this
restricted activity. In vitro transient transfections of retinoblas-
toma and neuroblastoma cells and in vivo experiments with
transgenic Xenopus laevis indicate that 31783/+101 and 3156/
+101 IRBP gene fragments directed expression predominantly to
the retina and pineal, with minor neuronal expression elsewhere.
In contrast, a 370/+101 fragment was less restrictive in
controlling expression, exhibiting activity not only in retina,
but also in forebrain, hindbrain, spinal cord, and motor neurons
innervating gills. ß 2001 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The expression of interphotoreceptor retinoid binding pro-
tein (IRBP), a large glycolipoprotein found abundantly in the
interphotoreceptor matrix of many vertebrates [1^4], is limited
to photoreceptor cells of the retina and pinealocytes of the
pineal gland [5^7]. In exploring this tissue speci¢city, the cis
regulatory fragment of the IRBP 5P £anking region has been
progressively de¢ned through the work of several laboratories.
A 31783 to +101 fragment (relative to transcription start) of
the mouse IRBP gene drives reporter activity in transiently
transfected embryonic chick retina cells, but not in brain cells
or ¢broblasts [8]. Liou et al. [5] found that a 1.3 kb human
IRBP 5P £anking region drove reporter gene activity in trans-
genic mice and that a promoter fragment spanning 3156 to
+19 conferred tissue speci¢city [9]. Bobola et al. [10] and Fei
et al. [11] similarly found that 3123 to +18 of the human
IRBP gene drove reporter activity in transgenic mice, allowing
expression exclusively in the retina and pineal gland [10]. They
further found via DNase I footprinting that a 358 to 345
fragment, which is conserved across several species, bound
protein complexes from retinoblastoma cells but not lympho-
blasts or HeLa cells [10]. Similar results were obtained for the
mouse promoter using cultured cells [12].
Several groups demonstrated that the conserved region con-
tains cis elements that bind homeodomain trans-acting factors
such as CRX, OTX2, and RX and that exogenous expression
of these factors transactivates IRBP promoters in cultured
cells [10,12^18]. As CRX is expressed exclusively in photo-
receptors and pinealocytes with tightly regulated stage specif-
icity [13,14], it may be that the homeobox consensus region
mediates fully regulated IRBP expression. However, IRBP
expression persists in CRX knock-out mice [19]. Though other
homeodomain transcription factors can bind and transacti-
vate the IRBP promoter [16,18,20,21] and thus may substitute
for CRX in the CRX knock-out mouse [15], none are ex-
pressed exclusively in photoreceptor cells [22^25]. If the spe-
ci¢city of the IRBP promoter derives from the cell-speci¢c
expression of a transcription factor that binds it, then the
homeobox consensus region may mediate neuron speci¢city,
but not necessarily photoreceptor speci¢city.
In transient transfections of chick cell cultures, we found
that the 70 bp mouse IRBP promoter, which contains the
homeobox consensus region, was active in retina cells with
photoreceptor or neuron morphologies, and in separate cul-
tures of brain cells, but not in ¢broblasts. Conversely, the
promoter extending to 1783 bp was active only in retina cells
with photoreceptor morphology [12]. Thus, though the 70 bp
promoter fragment appears to allow high levels of promoter
activity, it is not clear that it provides for fully regulated, cell-
speci¢c expression. In this study, we sought to de¢ne the cis-
acting region of the mouse IRBP 5P £anking region that is
required for photoreceptor-restricted activity. Using in vitro
transient transfection assays and in vivo experiments with
transgenic Xenopus laevis, we found that elements 5P to posi-
tion 370 are required for photoreceptor-restricted reporter
gene expression.
2. Materials and methods
2.1. Cell culture, transient transfections, and CAT assays
Cell lines were obtained from the American Type Culture Collec-
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tion (ATCC, Manassas, VA, USA) and established as per ATCC
instructions. Cells were maintained at 37‡C in 5% CO2. WERI-Rb1
retinoblastoma (ATCC HTB-169) and CATH.a neuroblastoma
(ATCC CRL-11179) cells were grown in RPMI 1640 medium (Media-
tech, Herdon, VA, USA) supplemented with 10% heat-inactivated
fetal bovine serum (Hyclone, Logan, UT, USA), 100 U/ml penicillin
G, 100 Wg/ml streptomycin (Gibco-BRL, Grand Island, NY, USA)
and 1 mM HEPES (Gibco-BRL), with renewal every 3^4 days and
1:4 splitting weekly. Neuro2a neuroblastoma cells (ATCC CCL-131)
and 293 human embryonic kidney cells (HEK 293; ATCC CRL-1573)
were grown in Eagle’s minimum essential medium (ATCC) supple-
mented with 10% fetal bovine serum (Hyclone), 100 U/ml penicillin
G and 100 Wg/ml streptomycin (Gibco-BRL), with renewal every 3^4
days and 1:4 splitting weekly.
All cells were plated at 5U105 cells per 35 mm culture well in 1 ml
of growth medium and transfected within 24 h. WERI retinoblastoma
and human kidney 293 cells were transfected with Superfect (Qiagen,
Valencia, CA, USA) as per the manufacturer’s instructions: 1 Wg of
plasmid DNA was added to 1 Wl Superfect in a total of 100 Wl of
OptiMem medium (Gibco-BRL). This solution was added dropwise to
a well of cells. CATH.a and Neuro2a neuroblastoma cells were trans-
fected using E¡ectene (Qiagen) as per the manufacturer’s instructions:
16 Wl Enhancer and 50 Wl of E¡ectene were added to 2 Wg of plasmid
DNA previously diluted into 100 Wl of EC bu¡er. This solution was
added dropwise to a well of cells.
Following a 48 h incubation at 37‡C in 5% CO2, cells were har-
vested and assayed for chloramphenicol acetyltransferase (CAT) ac-
tivity as previously described [8]. Brie£y, cell cytoplasm solutes were
mixed with tritiated acetyl CoA and chloramphenicol and added to an
organic scintillation liquid. CAT activity was measured as the accu-
mulation of [3H]acetylchloramphenicol over time on an LS6500 scin-
tillation counter (Beckman Instruments). CAT activity is reported as
CAT enzyme unitsU1033. Each transfection group had a sample size
of three to six per experiment. Each experiment was repeated at least
three times. Data shown are representative.
2.2. Transgenic Xenopus laevis
These studies adhered to the Association for Research in Vision and
Ophthalmology statement for the use of animals in ophthalmic and
vision research. IRBP-enhanced green £uorescent protein (EGFP)
plasmids were linearized using XhoI and transgenic Xenopus laevis
embryos were produced as described [26]. Promoter/reporter gene
fragments were excised and used to produce transgenic Xenopus tad-
poles by restriction enzyme-mediated integration. Embryos were ex-
amined every day for EGFP expression and those that exhibited non-
mosaic £uorescence above that from the yolk were studied further.
Non-£uorescent siblings served as controls. Typically, about 30% of
the tadpoles express EGFP and have integrated the plasmid. The
distribution of EGFP was evaluated in vivo and in frozen ocular
sections by conventional £uorescence microscopy and by confocal
microscopy.
2.3. Plasmid construction
The CAT plasmid vectors used were based on the promoterless
CAT vector pBLCAT3 (GenBank accession number X64409). The
plasmid pSV40-CAT contained the SV40 promoter and enhancer re-
gions (pCAT Control; Promega, Madison, WI, USA). The experi-
mental plasmid pIRBP1783-CAT was constructed by inserting into
pBLCAT3 a BamHI fragment from 31783 to +101 (relative to tran-
scription start) of the murine IRBP sequence (GenBank accession
number M32734). A nested set of deletions based on this plasmid
was prepared by the ExoIII/mung bean nuclease method. The frag-
ments generated had 5P ends corresponding to 3156 and 370 of the
murine IRBP gene and are referred to by those numbers.
The EGFP plasmids used in producing transgenic Xenopus were
based on the promoterless pEGFP-1 reporter vector (Clontech Labo-
ratories, Palo Alto, CA, USA; GenBank accession number U55761),
which served as negative control. Experimental plasmids pIRBP1783-
EGFP and pIRBP156-EGFP were constructed by inserting a BamHI
fragment of the murine IRBP gene (bases 31783 and 3156 to +101
relative to transcription start) into pEGFP-1. The plasmid pIRBP70-
EGFP was constructed by inserting a HindIII/BamHI fragment from
the murine IRBP gene (370 to +101 relative to transcription start)
into pEGFP-1.
2.4. Statistical analyses
Numerical data are means of groups þ S.D. Statistical di¡erences
were determined by simple analysis of variance followed by New-
man-Keuls post hoc testing. P values and sample size per experiment
are given in ¢gure legends.
Fig. 1. E¡ect of truncation on IRBP promoter activity in expressing
and non-expressing cell lines. Human WERI-Rb1 retinoblastoma
cells, mouse CATH.a or Neuro2a neuroblastoma cells, and HEK
293 cells were transiently transfected with CAT reporter constructs
containing IRBP gene fragments (31783, 3156, and 370 to +101,
relative to transcription start; ‘1783’, ‘156’, and ‘70’, respectively),
an SV40 promoter (‘SV40’), or no promoter (‘None’; pSVOAT-
CAT). CAT activity, as measured by radioenzymatic assay, was
used as an index of promoter activity. Ordinate values are 1033
CAT activity units. Error bars represent S.D.; some S.D.s were too
small for bars to be seen. A: The three IRBP promoters are active
in retinoblastoma cells (left panel, n = 5/group, P6 0.05 vs. ‘None’).
Conversely, in HEK 293 cells, only the SV40 promoter was active
(right panel, P6 0.05, n = 3/group). B: Though they were equally
active in retinoblastoma cells, the 31783/+101 promoter was much
less active in neuroblastoma cells than the 370/+101 promoter
(P6 0.05, n = 4^5/group). C: The 3156/+101 promoter was much
less active in neuroblastoma cells than the 370/+101 promoter
(P6 0.05; n = 6/group).
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3. Results
3.1. IRBP promoter activity in cultured cells
In transient transfections of HEK 293 cells, the SV40 pro-
moter was active, but not the IRBP promoters (Fig. 1A). In
transient transfections of WERI-Rb1 retinoblastoma cells,
pIRBP70-CAT, pIRBP156-CAT, and pIRBP1783-CAT were
active to similar levels (Fig. 1A,B). In contrast, in transiently
transfected Neuro2a or CATH.a neuroblastoma cells,
pIRBP70-CAT consistently produced activity higher than
pIRBP1783-CAT (Fig. 1B) or pIRBP156-CAT (Fig. 1C).
These data suggest that an element between 3156 and 370
of the mouse IRBP promoter is required for tissue-restricted
activity in the relatively arti¢cial environment of immortal-
ized, cultured cells.
3.2. IRBP promoter activity in transgenic X. laevis
For each construct, several expressing transgenic frogs were
produced. For pIRBP1783-EGFP, 10 animals were EGFP-
positive and examined at the dissecting microscope. Four
were sectioned. For pIRBP156-EGFP, 24 of 40 animals
were EGFP-positive at 2 weeks. Three were raised to adult-
hood. Five were sectioned and examined by confocal micros-
copy. For pIRBP70-EGFP, 19 of 56 animals were EGFP-pos-
itive at 2 weeks. Four were raised to adulthood. Five were
sectioned and examined by confocal microscopy. EGFP ex-
pression levels varied with a construct group, estimated at
about ¢vefold based upon observations with the dissecting
microscope, most likely re£ecting varying number of trans-
genes in each animal. However, there was little variation in
spatial expression pattern for each construct. Typical embryos
are shown in the ¢gures.
Similar to results in transiently transfected cells, transgenic
Xenopus expressing EGFP under the control of the various
IRBP promoter fragments showed marked di¡erences in tis-
sue and cell type expression. Transgenic animals containing
the EGFP gene linked to either the 31783/+101 or 3156/
+101 IRBP promoter fragments showed £uorescence only in
eyes and possibly pineal gland (Fig. 2A,B), with more variable
and much lower expression levels in neurons in the ventral
head region and forebrain. In retina, the 3156/+101 promoter
fragment drove EGFP expression almost exclusively in the
photoreceptor cell layer (Fig. 2B). In contrast, the 370/+101
promoter fragment drove EGFP expression not only in retina,
but also in forebrain, hindbrain, spinal cord, and motor neu-
rons innervating gills (Fig. 2C). These data suggest that an
element between 3156 and 370 of the IRBP promoter is
required to restrict expression in a tissue-speci¢c fashion in
vivo.
4. Discussion
We previously found that pIRBP1783-CAT and pIRBP70-
CAT produced high levels of CAT expression in transiently
transfected primary cultures of embryonic chick retina cells
[8,12]. pIRBP70-CAT was additionally active in primary cul-
tures of embryonic chick brain cells and also cells with neu-
ron-like morphologies in retina cell cultures, suggesting that
an element between 31783 and 370 is required to restrict
promoter activity to photoreceptor cells [8,12]. In the present
study, we ¢nd that this di¡erential activity extends to species
beyond chicken. Additionally, the location of the putative
Fig. 2. E¡ect of truncation on IRBP promoter activity in EGFP-
transgenic X. laevis tadpoles. The 31783/+101, 3156/+101, or 370/
+101 IRBP promoters were inserted upstream of the EGFP gene
and the resulting promoter/EGFP fragment was used to produce
transgenic Xenopus tadpoles by restriction enzyme-mediated integra-
tion. Fluorescence was used as an index of promoter activity. A: A
pIRBP1783-EGFP transgenic tadpole, 5 days old. EGFP was ex-
pressed in the eye (E) and possibly pineal gland of the brain (B). B:
Radial cross section through the central retina of an eye from a
pIRBP156-EGFP transgenic tadpole, 3 weeks old (£uorescence mi-
croscopy in left panel, di¡erential interference contrast image in
right panel). The rod and cone photoreceptor cells of the outer reti-
na and possibly a few other neuronal cells of the inner retina ex-
pressed EGFP. C: Several views of a pIRBP70-EGFP transgenic
tadpole, 3^4 weeks old. Many types of neuronal structures, includ-
ing the eyes, brain, motor neurons, and spinal cord, expressed
EGFP. Top panels: Dorsal views showing the eye, forebrain, motor
neurons innervating gills, and spinal cord express EGFP. The hind-
brain is partially obscured by skin pigmentation (see lower right
panel). Note that as reported previously [26] the pronephros auto-
£uoresces in control animals (data not shown). Lower panels: Ven-
tral views showing EGFP expression in the same structures and also
the hindbrain. Note that the re£ection of the illuminating beam
from the gut lining in the lower right panel gives a false signal.
E = eye, G = gut, FB = forebrain, HB = hindbrain, SC = spinal cord,
gl = gills, and P = pronephros.
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restriction element has been further de¢ned. All three mouse
IRBP 5P £anking regions (31783/+101, 3156/+101, and 370/
+101) provide high promoter activity in a human cell line and
in vivo in Xenopus. All three activities appear to be restricted
to neuronal or sensory cells. However, only the activities of
the longer promoter fragments (31783/+101 or 3156/+101)
appear to be additionally restricted to photoreceptors and
pineal cells, mimicking the endogenous expression of IRBP.
These data indicate that a 370 to +101 bp fragment of the
mouse IRBP gene, which contains functional cis elements that
bind CRX, OTX2, and RX [11^14,16,18,20,21], can act as a
strong promoter, but silencing elements between 370 and
3156 are required for cell-restricted expression.
This conclusion suggests that the restricted expression of
endogenous IRBP in part requires the presence of a silencing
mechanism in all cell types except photoreceptors or pinealo-
cytes. Though this may appear unlikely, such regulatory
mechanisms exist. The neuron-restrictive silencer factor
(NRSF) represses transcription of over 20 neuronal genes in
non-neuronal cells by binding to the neuron-restrictive si-
lencer element (NRSE) [27,28]. In some instances, NRSF ex-
ists in neurons and stimulates transcription of neuron-speci¢c
genes, yet in non-neuronal cells, it inhibits the expression of
those same genes [29]. Another neuron-restricting transcrip-
tion mechanism, distinct from NRSF/NRSE, involves the
SNOG consensus sequence, which regulates the neuron-re-
strictive expression of the genes SNAP-25, nNOS, and
GAP-43 (‘SNOG’ derives from these gene names) [30,31].
SNOG does not bind a neuron-speci¢c transcription factor.
Rather, its presence in a gene is su⁄cient to block the tran-
scription of that gene in non-neuronal cells that would other-
wise be driven by a ubiquitous AP-1 element [31]. SNOG
neuronal gene expression is additionally mediated in neurons
by speci¢c transcription factors.
Our data and those of other laboratories do not contradict
the existence of similar transcription mechanisms that might
be photoreceptor-speci¢c and would require the presence of
elements between 3156 and 370. Several laboratories have
reported that elements between 3156 and 370 of the IRBP
gene bind nuclear protein complexes from both retinal and
non-retinal cells [10,12,16]. Additionally, an element from
the human IRBP gene (3206 to 366 relative to transcription
start) prevents transactivation of promoter/reporter constructs
by exogenous OTX2 expression in transiently transfected
HeLa cells [16]. That CRX-de¢cient mice express IRBP
mRNA [15] suggests that non-CRX homeodomain factors
can bind and activate the homeobox elements in the short
IRBP promoter. Such a role has been suggested for OTX2
[16,18] and RX [20]. However, both of these factors are ex-
pressed in photoreceptor and non-photoreceptor cells [22^25].
Left unchecked, they should induce ectopic IRBP expression,
suggesting that, since such expression does not occur, restric-
tive IRBP gene regulatory mechanisms are likely to exist. The
exciting ¢nding that MOK2 inhibits in vitro IRBP promoter
activity [32] may prove useful in identifying potential suppres-
sive mechanisms, though this is complicated by the observa-
tion that MOK2 is expressed endogenously in photoreceptors
[32].
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